Log in

Relevant bibliographies by topics / Liquid Embolic Agents

Contents

Journal articles
Book chapters
Conference papers

Academic literature on the topic 'Liquid Embolic Agents'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Liquid Embolic Agents.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Liquid Embolic Agents"

1

Mason, JR, C. Dodge, and G. Benndorf. "Quantification of tantalum sedimentation rates in liquid embolic agents." Interventional Neuroradiology 24, no. 5 (2018): 574–79. http://dx.doi.org/10.1177/1591019918773443.

Full text

Abstract:

Background Endovascular treatment (EVT) of brain arteriovenous malformations has evolved from cyanoacrylate derivatives such as N-butyl cyanoacrylate, an adhesive glue, to ethylene vinyl copolymer-based liquid embolics such as Onyx® and SQUID® dissolved in dimethyl sulfoxide. Although these agents offer several advantages, their rapidly decreasing radiopacity, as a result of the sedimentation of tantalum powder, compromises visual control during EVT. This study aims to quantify and compare tantalum sedimentation rates of several liquid embolic agents, and determine their effects on radiopacity

APA, Harvard, Vancouver, ISO, and other styles

2

He, Ji’an, Mei Li, Yan Xu, et al. "In vitro characteristics of Epirubicin-loaded thermosensitive liquid embolic agent." Journal of Cancer Research and Therapeutics 19, no. 6 (2023): 1597–602. http://dx.doi.org/10.4103/jcrt.jcrt_334_23.

Full text

Abstract:

Objective: To investigate the drug loading and release rate of epirubicin-loaded thermosensitive liquid embolic agents in vitro. Materials and Methods: The drug loading and stability of epirubicin-loaded thermosensitive liquid embolic agents with or without iopromide were determined by high-performance liquid chromatography, and the same method was used to determine the drug release rate of thermosensitive liquid embolic agents at different time points. Results: For epirubicin-loaded thermosensitive liquid embolic agents without iopromide, the average drug loading after filtration by membrane

APA, Harvard, Vancouver, ISO, and other styles

3

Pal, Amrita, Jeffrey Blanzy, Karime Jocelyn Rosas Gómez, Mark C. Preul, and Brent L. Vernon. "Liquid Embolic Agents for Endovascular Embolization: A Review." Gels 9, no. 5 (2023): 378. http://dx.doi.org/10.3390/gels9050378.

Full text

Abstract:

Endovascular embolization (EE) has been used for the treatment of blood vessel abnormalities, including aneurysms, AVMs, tumors, etc. The aim of this process is to occlude the affected vessel using biocompatible embolic agents. Two types of embolic agents, solid and liquid, are used for endovascular embolization. Liquid embolic agents are usually injectable and delivered into the vascular malformation sites using a catheter guided by X-ray imaging (i.e., angiography). After injection, the liquid embolic agent transforms into a solid implant in situ based on a variety of mechanisms, including p

APA, Harvard, Vancouver, ISO, and other styles

4

Young, Shamar, Alessandro Gasparetto, and Jafar Golzarian. "Liquid Embolics: A Guide to Currently Available and Pipeline Products." Digestive Disease Interventions 06, no. 01 (2021): 013–18. http://dx.doi.org/10.1055/s-0041-1740266.

Full text

Abstract:

AbstractOver the last decade, several publications have reported the safety and efficacy of liquid embolics in a wide range of clinical indications. The expansion of clinical scenarios in which liquid embolics are utilized has been in part driven by some of the advantages these materials hold over other embolic agents. For instance, liquid embolics do not rely on the patient's ability to form clot and can be delivered more distally then coils at times. While several liquid embolics are commercially available, and in some cases have been for decades, there are limitations to these materials as

APA, Harvard, Vancouver, ISO, and other styles

5

Ko, Giho, Jin Woo Choi, Nohyun Lee, Dokyoon Kim, Taeghwan Hyeon, and Hyo-Cheol Kim. "Recent progress in liquid embolic agents." Biomaterials 287 (August 2022): 121634. http://dx.doi.org/10.1016/j.biomaterials.2022.121634.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Jiang, Yonghe, Yang Zhang, Zhixiang Lu, et al. "Liquid embolic agents for interventional embolization." ChemPhysMater 1, no. 1 (2022): 39–50. http://dx.doi.org/10.1016/j.chphma.2021.09.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Leyon, Joe J., Swarupsinh Chavda, Allan Thomas, and Saleh Lamin. "Preliminary experience with the liquid embolic material agent PHIL (Precipitating Hydrophobic Injectable Liquid) in treating cranial and spinal dural arteriovenous fistulas: technical note." Journal of NeuroInterventional Surgery 8, no. 6 (2015): 596–602. http://dx.doi.org/10.1136/neurintsurg-2015-011684.

Full text

Abstract:

BackgroundLiquid embolic agents are the preferred embolic material in endovascular treatment of pial and brain arteriovenous malformations and dural arteriovenous fistulas (DAVFs). There is little choice available in interventional neuroradiology practice other than two of the most commonly used liquid embolic agents—n-butyl cyanoacrylate and the Onyx liquid embolic system (ev3 Neurovascular, Irvine, California, USA). PHIL (Precipitating Hydrophobic Injectable Liquid) (Microvention, Inc California, USA) is a new liquid embolic agent, CE marked and available for clinical use in Europe.Objective

APA, Harvard, Vancouver, ISO, and other styles

8

Tiralongo, Francesco, Giulio Distefano, Monica Palermo, et al. "Liquid and Solid Embolic Agents in Gonadal Veins." Journal of Clinical Medicine 10, no. 8 (2021): 1596. http://dx.doi.org/10.3390/jcm10081596.

Full text

Abstract:

Male varicocele and pelvic congestion syndrome (PCS) are common pathologies with high predominance in young patients, having a high impact on the quality of life and infertility. Lately, the use of different endovascular embolization techniques, with various embolizing agents, shows good technical results and clinical outcomes. With the aim of presenting the “state of the art” of endovascular techniques for the treatment of male varicocele and PCS, and to discuss the performance of the different embolic agents proposed, we conducted an extensive analysis of the relevant literature and we repor

APA, Harvard, Vancouver, ISO, and other styles

9

Sirakov, Stanimir S., Alexander Sirakov, Krasimir Minkin, et al. "Initial experience with precipitating hydrophobic injectable liquid in cerebral arteriovenous malformations." Interventional Neuroradiology 25, no. 1 (2018): 58–65. http://dx.doi.org/10.1177/1591019918798808.

Full text

Abstract:

Background Precipitating hydrophobic injectable liquid is a newly introduced liquid embolic agent for endovascular embolization with some technical advantages over other liquid embolic agents. We present our initial experience with precipitating hydrophobic injectable liquid in the endovascular treatment of cerebral arteriovenous malformations. Methods From October 2015 to January 2018, 27 patients harboring cerebral arteriovenous malformations underwent endovascular embolization with precipitating hydrophobic injectable liquid 25. Clinical features, angiographic results, procedural details, c

APA, Harvard, Vancouver, ISO, and other styles

10

International, Journal of Medical Science and Innovative Research (IJMSIR). "Advancing Vascular Care: Development of Steerable Microcatheter with Detachable Tip for Liquid Embolization of Vascular Aneurysm: In-vitro Analysis." International Journal of Medical Science and Innovative Research (IJMSIR) 9, no. 6 (2024): 149–58. https://doi.org/10.5281/zenodo.15449671.

Full text

Abstract:

<strong>Abstract</strong> Ongoing advancements in vascular intervention are fueled by the pursuit of improved patient outcomes and procedural efficiency. This study presents a newly developed steerable microcatheter tailored for the delivery and retrieval of liquid embolic agents in vascular procedures, specifically targeting the obstruction of blood flow to aneurysms. Key to this research is the incorporation of a biocompatible and embolization tip that can be detached from the steerable microcatheter body using thermoplastic sleeves. This research distinguishes itself by utilizing medical-gr

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Liquid Embolic Agents"

1

Kondo, Kimi. "Liquid Embolic Agents." In Transcatheter Embolization and Therapy. Springer London, 2010. http://dx.doi.org/10.1007/978-1-84800-897-7_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Howington, Jay U., Charles W. Kerber, Lee R. Guterman, and L. Nelson Hopkins. "Liquid Embolic Agents in the Treatment of Intracranial Arteriovenous Malformations." In Neuroendovascular Surgery. KARGER, 2005. http://dx.doi.org/10.1159/000082950.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Liu, Jing, and Liting Yi. "Liquid Metal as Vascular Embolic Agent in Tumor Therapy." In Liquid Metal Biomaterials. Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-5607-9_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Li, Yongjiang, Dominique Barthes-Biesel, and Anne-Virginie Salsac. "Therapeutic Embolization by Cyanoacrylate Liquid Glues Mixed with Oil Contrast Agent: Time Evolution of the Liquid Emboli." In IFMBE Proceedings. Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-9023-3_24.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Chudyk, Jorge, Esteban Scrivano, Nicolas Perez, Carlos Bleise, and Pedro Lylyk. "Middle Cerebral Artery Aneurysm: Ruptured Mycotic Distal Aneurysm: Treatment by Deconstructive Technique Using a Liquid Embolic Agent." In The Aneurysm Casebook. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-70267-4_53-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Chudyk, Jorge, Esteban Scrivano, Nicolas Perez, Carlos Bleise, and Pedro Lylyk. "Middle Cerebral Artery (M3) Aneurysm: Ruptured Mycotic Distal Aneurysm: Treatment by Deconstructive Technique Using a Liquid Embolic Agent." In The Aneurysm Casebook. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-77827-3_53.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Arslan, Muhammet, Celal Cinar, and Ismail Oran. "Embolization of Spinal Dural Arteriovenous Fistulae Using a Nonadhesive Liquid Embolic Agent Delivered Via a Dual-Lumen Balloon Catheter." In Intracranial and Spinal Dural Arteriovenous Fistulas. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-5767-3_17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Cohen, José E. "Suboccipital Cerebellar Arteriovenous Malformation with Prenidal Aneurysms Presenting with Subarachnoid Hemorrhage: Intraprocedural Aneurysm Rupture, Embolization Using Detachable Tip Microcatheters and EVOH-Based Liquid Embolic Agent with Complete AVM Exclusion and Excellent Clinical Evolution." In The Arteriovenous Malformations and Fistulas Casebook. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-51200-2_22-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Cohen, José E., Samuel Moscovici, Issael J. Ramirez, and Sergey Spektor. "Temporal Pial Arteriovenous Malformation Presenting with Headaches: Embolization Utilizing Detachable Tip Microcatheter and EVOH-Based Liquid Embolic Agent, Near Total Occlusion Complicated with Early Venous Compromise and Massive Hemorrhage; Emergency Surgery, Hematoma Evacuation, and AVM Removal with Excellent Clinical Outcome." In The Arteriovenous Malformations and Fistulas Casebook. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-51200-2_18-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

"29 Aneurysm Embolization with Liquid Embolic Agents." In Video Atlas of Neuroendovascular Procedures, edited by Leonardo Rangel-Castilla, Adnan H. Siddiqui, Giuseppe Lanzino, L. Nelson Hopkins, Jason M. Davies, and Elad I. Levy. Georg Thieme Verlag, 2020. http://dx.doi.org/10.1055/b-0040-175276.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Liquid Embolic Agents"

1

Mason, J. "O-015 Comparison of image quality of liquid embolic agents." In SNIS 16TH ANNUAL MEETING. BMJ Publishing Group Ltd., 2019. http://dx.doi.org/10.1136/neurintsurg-2019-snis.15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Gounis, Matthew J., Baruch B. Lieber, and L. Nelson Hopkins. "Polymerization of Enbucrilate/Lipiodol Mixtures In Vivo." In ASME 2000 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2000. http://dx.doi.org/10.1115/imece2000-2568.

Full text

Abstract:

Abstract Embolization is an endovascular procedure used to treat cerebral arteriovenous malformations (AVMs). AVMs are pathological shunts between arteries and veins, which bypass normal brain structures. An embolic agent commonly used to occlude AVMs is n-butyl 2-cyanoacrylate (NBCA). Although NBCA has shown to be efficacious for this application, precise knowledge of its polymerization process in vivo is needed. Inadvertent occlusion of arterial feeders proximal to the AVM nidus will occur when polymerization of NBCA is too rapid. This may lead to revascularization of the AVM. Conversely, lo

APA, Harvard, Vancouver, ISO, and other styles

3

McClanahan, A., G. Vilanilam, A. Rezayev, et al. "E-124 Clinicoradiologic outcomes comparing particle and liquid embolic agents in middle meningeal artery embolization." In SNIS 22nd Annual Meeting Abstracts. BMJ Publishing Group Ltd., 2025. https://doi.org/10.1136/jnis-2025-snis.240.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Lieber, B. B., A. K. Wakhloo, A. Divani, and S. Rudin. "Determination of Vascular Geometry and Flow Velocity in Cerebral Arteriovenous Malformations (AVMs) Using Double Contrast and High-Speed Digital Subtraction Angiography." In ASME 1998 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1998. http://dx.doi.org/10.1115/imece1998-0027.

Full text

Abstract:

Abstract Successful therapeutic embolization, i.e., catheter-based occlusion of cerebral arteriovenous malformations (AVMs) using liquid embolic agents requires precise knowledge of highly variant AVM architecture, blood flow velocity, and transit times through the AVM fistulae. In this study we tried to visualize both the AVM vascular substructure and dynamics of discrete microdroplets traveling through the AVM using a single injection composed of both soluble and non-soluble contrast material. The contrast injection is traced with high-speed digital subtraction angiography. This novel techni

APA, Harvard, Vancouver, ISO, and other styles

5

Gajjar, A., J. Chen, D. Tzorfas, and A. Paul. "E-004 Cost comparison of liquid versus particulate embolic agents for middle meningeal artery embolization in chronic subdural hematoma." In SNIS 22nd Annual Meeting Abstracts. BMJ Publishing Group Ltd., 2025. https://doi.org/10.1136/jnis-2025-snis.120.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Mowla, A., S. Abdollahifard, A. Farrokhi, O. Yousefi, A. Valibeygi, and P. Azami. "E-169 Middle meningeal artery embolization with liquid embolic agents for chronic subdural hematoma: a systematic review and meta-analysis." In SNIS 20th Annual Meeting Abstracts. BMJ Publishing Group Ltd., 2023. http://dx.doi.org/10.1136/jnis-2023-snis.268.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Dahl, R., M. Krogager, V. Eskesen, L. Poulsgaard, and G. Benndorf. "E-008 Direct trans-fistulous occlusion of high-grade DAVFs – A forgotten but effective technique in times of liquid embolic agents." In SNIS 21st Annual Meeting Abstracts. BMJ Publishing Group Ltd., 2024. http://dx.doi.org/10.1136/jnis-2024-snis.113.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sioutas, G., J. Vivanco-Suarez, O. Shekhtman, et al. "E-010 Liquid embolic agents for middle meningeal artery embolization in chronic subdural hematoma: an institutional experience with systematic review and meta-analysis." In SNIS 20th Annual Meeting Abstracts. BMJ Publishing Group Ltd., 2023. http://dx.doi.org/10.1136/jnis-2023-snis.110.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Salem, M., J. Khalife, O. Kuybu, et al. "O-022 Comparative analysis of particles versus liquid embolic agents’ efficacy for middle meningeal artery embolization of chronic subdural hematomas: multicenter experience of 956 embolizations." In SNIS 20th Annual Meeting Abstracts. BMJ Publishing Group Ltd., 2023. http://dx.doi.org/10.1136/jnis-2023-snis.22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Jagadeesan, B., S. Moen, R. Tummala, and A. Grande. "P-001 A simple animal model for the pre-clinical evaluation of liquid embolic agents and adjunctive devices used in transvenous retrograde embolization of arteriovenous malformations." In SNIS 15TH ANNUAL MEETING, July 23–26, 2018, Hilton San Francisco Union Square San Francisco, CA. BMJ Publishing Group Ltd., 2018. http://dx.doi.org/10.1136/neurintsurg-2018-snis.37.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!